Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 324

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 2
Chunk 324
---
 the exercise
price of the warrants in lieu of cash proceeds.

On February 15, 2024, the Company
issued 50,000 shares of Common Stock for consulting services valued at $100,000.

    F-23

On
February 15, 2024, the Company closed a private placement of 344,827 shares of Common Stock, $0.0001 par value, at $2.90 per share for
aggregate proceeds to the Company of $1,000,000 in cash. 

On February 16, 2024, the Company
recognized 3,425,399 shares of Common Stock to be issued in settlement of the contingent consideration as a result of the Company’s
acquisition of GEDi Cube Intl Ltd.

On
February 13, 2024, the Company issued 70,834,183 shares of Common Stock valued at $136,001,631 (see Note 13) pursuant to the Stock Purchase
Agreement of Renovaro Cube.

On December 4, 2023, the Company
issued 525,945 shares of Common Stock pursuant to warrants exercised for cash proceeds of $341,865.

On October 23, 2023, the Company
issued 1,000,000 shares of Common Stock valued at $2,760,000 for advisory services to Avram Miller, a member of the Company’s board
of directors.

Between July 28, 2023, and September
28, 2023, the Company issued 2,000,000 shares of Common Stock for consulting services valued at $4,470,000.

2017
Warrants

On July
14, 2022, certain of our warrant holders exercised warrants to purchase 1,250,000 shares of Common Stock for total proceeds
to the Company of $1,625,000, with corresponding earn-out distribution of the same number of shares in connection with the acquisition
of Renovaro Biosciences. This non-cash earn-out distribution impacted stockholders’ equity in the amount of $2,762,500 based
on the share price on July 14, 2022 of $2.21. The Company recorded a loss on extinguishment of contingent consideration liability of $419,182 during
the year ended June 30, 2024 which reflected the difference between the fair value of the shares and the contingent consideration liability
at the time of extinguishment. As of June